672 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 14 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
HTR1A5-hydroxytryptamine receptor 1ADisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HTR1B5-hydroxytryptamine receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
HTR1D5-hydroxytryptamine receptor 1DFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
HTR1E5-hydroxytryptamine receptor 1EFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
HTR1F5-hydroxytryptamine receptor 1FFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR2A5-hydroxytryptamine receptor 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine receptor 2BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
NucleoplasmTissue enhanced
HTR2C5-hydroxytryptamine receptor 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR3A5-hydroxytryptamine receptor 3AFDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
HTR3B5-hydroxytryptamine receptor 3BFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR3C5-hydroxytryptamine receptor 3CFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
HTR3D5-hydroxytryptamine receptor 3DFDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
HTR3E5-hydroxytryptamine receptor 3EFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR45-hydroxytryptamine receptor 4FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR65-hydroxytryptamine receptor 6FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
HTR75-hydroxytryptamine receptor 7FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cytosol
Group enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Expressed in all
IDEInsulin degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
IFNAR1Interferon alpha and beta receptor subunit 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolExpressed in all
IFNAR2Interferon alpha and beta receptor subunit 2Cancer-related genes
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
IFNGInterferon gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IFNGR1Interferon gamma receptor 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IFNGR2Interferon gamma receptor 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Golgi apparatus
Mixed
IGF1RInsulin like growth factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesMixed
IKBKBInhibitor of nuclear factor kappa B kinase subunit betaCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
CytosolMixed
IL11RAInterleukin 11 receptor subunit alphaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL12BInterleukin 12BDisease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Not detected
IL17AInterleukin 17ACancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IL1BInterleukin 1 betaCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
IL1R1Interleukin 1 receptor type 1Cancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL23AInterleukin 23 subunit alphaFDA approved drug targets
Predicted secreted proteins
CytosolTissue enhanced
IL2RAInterleukin 2 receptor subunit alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor subunit betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor subunit gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
VesiclesTissue enhanced
IL3RAInterleukin 3 receptor subunit alphaCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
IL5Interleukin 5Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
IL6Interleukin 6Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
IL6RInterleukin 6 receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
IMPDH1Inosine monophosphate dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Cytosol
Rods & Rings
Expressed in all
IMPDH2Inosine monophosphate dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Cytosol
Rods & Rings
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesExpressed in all
ITGA2BIntegrin subunit alpha 2bCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGA4Integrin subunit alpha 4Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneTissue enhanced
ITGALIntegrin subunit alpha LCD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGAVIntegrin subunit alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Focal adhesion sites
Cytosol
Expressed in all
ITGB1Integrin subunit beta 1Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites
Expressed in all
ITGB3Integrin subunit beta 3Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB7Integrin subunit beta 7Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Mixed
JAK1Janus kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Focal adhesion sites
Mixed
« prev | Page of 14 | next »